Pneumatic Compression Therapy Market Report and Forecast 2025-2034

The global pneumatic compression therapy market was valued at USD 4.00 Billion in 2024, driven by the rising cases of blood circulation-related disease across the globe. The market is anticipated to grow at a CAGR of 5.70% during the forecast period of 2025-2034 to achieve a value of USD 6.96 Billion by 2034.

Pneumatic Compression Therapy Market Overview

Pneumatic compression therapy is a non-invasive treatment that uses inflatable sleeves or garments to apply controlled pressure to the limbs, promoting blood circulation and lymphatic drainage. It is commonly used for lymphedema, deep vein thrombosis (DVT) prevention, chronic venous insufficiency, and post-surgical recovery. The therapy helps reduce swelling, improve oxygen delivery, and prevent fluid buildup, enhancing overall vascular health. Modern pneumatic compression devices feature adjustable pressure settings and sequential compression patterns for personalised treatment. This therapy is widely used in clinical, rehabilitation, and home care settings to support faster recovery and improved mobility.

Global Pneumatic Compression Therapy Market Growth Drivers

Wireless Innovations Driving Market Growth

The rising demand for portable recovery solutions and advancements in wireless compression therapy devices are significantly shaping the market. For instance, in October 2024, Hyperice launched Normatec Elite, a wireless, lightweight air compression boot with seven compression levels, independent controls, and app connectivity. The device eliminates hoses and separate control units, making it highly portable and user-friendly. As consumer preference shifts towards tech-driven and mobile recovery solutions, this innovation is expected to drive market growth, increasing adoption among athletes, physiotherapists, and individuals seeking effective at-home compression therapy during the forecast period.

Advancements in Patient Care to Enhance Pneumatic Compression Therapy Market Value

The market is expanding due to rising awareness of venous thromboembolism (VTE) prevention and increasing demand for hospital-based intermittent pneumatic compression (IPC) devices. For instance, in November 2024, Cardinal Health introduced the Kendall SCD SmartFlow Compression System, a next-generation IPC device designed to enhance blood circulation, prevent VTE, and reduce swelling in at-risk patients. Featuring clinically proven, customisable intermittent compression technology, this system aims to improve patient outcomes and hospital efficiency. With hospitals and healthcare providers adopting advanced IPC solutions, the market is expected to witness significant development, driven by technological advancements and increasing applications in post-surgical and preventive care.

Pneumatic Compression Therapy Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Adoption of Pneumatic Compression Therapy Across Various Indications

The growing body of clinical evidence supporting pneumatic compression therapy is driving higher adoption rates in the lymphedema treatment. The September 2024 study by Tactile Systems Technology, Inc., published in the Journal of Vascular Surgery, Venous and Lymphatic Disorders, demonstrated significant quality-of-life improvements with the Flexitouch advanced pneumatic compression device (APCD) in veterans with lower extremity lymphedema. As scientific validation strengthens insurance coverage, physician recommendations, and patient confidence, demand for clinically proven, home-based compression solutions is expected to increase, driving market expansion and innovation in pneumatic compression therapy devices.

Increasing Demand for Home-Based Therapy Solutions to Bolster Pneumatic Compression Therapy Market Demand

The rising prevalence of chronic venous disorders and lymphedema is driving demand for home-based pneumatic compression therapy devices. Patients seek convenient, non-invasive treatment options that enhance blood circulation, reduce swelling, and improve mobility. Technological advancements, including portable and user-friendly devices with smart monitoring features, are improving patient compliance and treatment outcomes. As healthcare systems encourage outpatient and home care settings to reduce hospital burden, the global pneumatic compression therapy market is expected to witness strong growth in home-use device adoption in the coming years.

Integration of Smart Technology to Enhance Pneumatic Compression Therapy Market Value

Technological advancements are transforming pneumatic compression therapy devices with smart features, including Bluetooth connectivity, real-time monitoring, and AI-driven customisation. These innovations allow patients and clinicians to track therapy sessions, optimise treatment settings, and enhance compliance. The integration of mobile apps and cloud-based data storage enables remote monitoring, reducing hospital visits and healthcare costs. As smart medical devices gain popularity, manufacturers are focusing on enhancing patient experience, improving therapy efficiency, and expanding market adoption through intelligent compression technology.

Growing Adoption in Post-Surgical Recovery to Impact the Pneumatic Compression Therapy Market Size Positively

Post-surgical rehabilitation is a key driver for the market, with increasing use in orthopaedic, vascular, and cosmetic surgery recovery. These devices help prevent deep vein thrombosis (DVT), reduce swelling, and accelerate healing. As minimally invasive and elective procedures rise globally, hospitals and clinics are incorporating pneumatic compression therapy into post-operative care protocols. The emphasis on faster recovery, reduced complications, and enhanced patient outcomes is fueling market growth, with manufacturers developing customised compression solutions tailored to specific surgical recovery needs.

Pneumatic Compression Therapy Market Segmentation

Pneumatic Compression Therapy Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

• Compression Wraps
• Compression Pumps
• Compression Braces
• Compression Stockings
• Compression Bandages
• Compression Tapes
• Others

Market Breakup by Techniques

• Static Compression Therapy
• Dynamic Compression Therapy

Market Breakup by Application

• Deep Vein Thrombosis
• Leg Ulcer
• Varicose Veins
• Lymphedema
• Others

Market Breakup by Distribution Channel

• Pharmacies and Retailers
• Hospitals and Clinics
• Online Retailers
• Home Care Settings

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Pneumatic Compression Therapy Market Share

Compression Pumps to Lead the Segment by Product

Compression pumps are set to hold the largest market share due to their high efficacy in treating venous and lymphatic disorders. The increasing prevalence of chronic venous insufficiency, lymphedema, and deep vein thrombosis (DVT) is driving demand. Technological advancements, such as automated pressure adjustments and portable designs, are further boosting adoption. The growing preference for non-invasive therapies and rising awareness among healthcare providers and patients will continue to propel this segment. Additionally, the expanding homecare sector and favourable reimbursement policies are expected to drive significant growth in the forecast period.

Dynamic Compression Therapy to Dominate the Pneumatic Compression Therapy Market Segmentation by Technique

Dynamic compression therapy is expected to dominate the market due to its superior effectiveness in improving blood circulation and reducing oedema compared to static alternatives. This technique is increasingly preferred for post-surgical recovery, sports injury rehabilitation, and chronic venous disorders. The development of smart compression systems with adjustable pressure controls enhances treatment outcomes, driving patient preference. Moreover, rising awareness of preventive healthcare and the growing elderly population prone to vascular diseases are key growth drivers. The integration of wearable compression devices will further bolster this segment’s market expansion in the coming years.

Lymphedema to Hold a Substantial Pneumatic Compression Therapy Market Value for Segmentation by Application

Lymphedema is set to hold the largest market share in the application segment, driven by the increasing incidence of cancer-related lymphatic complications and post-surgical swelling. The rising number of breast cancer surgeries and mastectomies has heightened the demand for pneumatic compression therapy. Additionally, the growing adoption of at-home lymphedema management solutions, coupled with advancements in compression pump technology, is further driving market expansion. Increased awareness campaigns and government initiatives promoting early diagnosis and effective treatment options are expected to strengthen this segment’s market presence during the forecast period.

Hospitals and Clinics Leading the Pneumatic Compression Therapy Market by Distribution Channel

Hospitals and clinics are poised to dominate the market as the primary point of care for vascular and lymphatic disorders. The growing number of surgeries, trauma cases, and chronic venous disease treatments is increasing demand for hospital-based pneumatic compression therapy. Additionally, hospitals benefit from strong reimbursement policies, advanced medical infrastructure, and trained healthcare professionals, ensuring optimal patient outcomes. The rising geriatric population, who frequently require specialist care for circulatory conditions, further drives this segment. The continuous integration of advanced compression devices into hospital settings will sustain its market leadership in the forecast period.

Pneumatic Compression Therapy Market Analysis by Region

North America is expected to dominate the market, driven by the high adoption of advanced medical devices, a growing elderly population, and increasing cases of venous disorders, lymphedema, and deep vein thrombosis (DVT). The United States is anticipated to lead due to favourable reimbursement policies, strong healthcare infrastructure, and extensive clinical research on compression therapy efficacy. Europe follows closely, supported by rising awareness, government healthcare initiatives, and a strong presence of key industry players. Asia-Pacific is witnessing rapid growth, fuelled by expanding healthcare facilities, increasing disposable income, and a growing focus on post-surgical recovery solutions. Meanwhile, Latin America and the Middle East & Africa show steady adoption, primarily in urban centres with advanced medical facilities.

Leading Players in the Pneumatic Compression Therapy Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Enovis Corporation

Enovis Corporation, headquartered in Wilmington, Delaware, USA, was established in 1995 and is a leading medical technology company focused on orthopaedic solutions and rehabilitation products. In the pneumatic compression therapy market, Enovis offers advanced devices for lymphedema, deep vein thrombosis (DVT) prevention, and post-surgical recovery. With a strong emphasis on innovation and patient-centric care, the company integrates cutting-edge technology into its compression systems. Enovis continues to expand its product portfolio, enhancing circulatory health, mobility, and recovery outcomes for patients worldwide through its clinically proven pneumatic compression solutions.

3M Company

Founded in 1902 and headquartered in Saint Paul, Minnesota, USA, 3M Company is a global leader in healthcare, industrial, and consumer products. In the pneumatic compression therapy market, 3M offers advanced compression solutions for wound care, venous insufficiency, and lymphedema management. Its portfolio includes innovative bandages, wraps, and intermittent pneumatic compression (IPC) devices, designed to enhance circulation and accelerate healing. With a strong R&D foundation, 3M continually develops cutting-edge compression technologies, improving patient outcomes and advancing medical treatments in hospitals, clinics, and homecare settings.

Julius Zorn GmbH

Julius Zorn GmbH, commonly known as Juzo, was established in 1912 and is headquartered in Aichach, Germany. The company is a renowned manufacturer of medical compression garments and therapy solutions, including pneumatic compression devices for lymphedema, venous disorders, and post-operative care. Juzo’s products are known for high-quality materials, custom-fit designs, and therapeutic effectiveness. With over a century of expertise, the company remains at the forefront of compression therapy innovation, continuously improving patient comfort and treatment efficiency while expanding its presence in global healthcare markets.

Convatec Group plc

Convatec Group plc, founded in 1978 and headquartered in Reading, United Kingdom, is a leading global medical products company specialising in advanced wound care, ostomy care, continence care, and compression therapy. Within the pneumatic compression therapy market, Convatec offers intermittent pneumatic compression (IPC) devices for lymphedema, venous insufficiency, and post-surgical recovery. The company is committed to enhancing patient mobility, improving healing rates, and reducing complications through clinically validated, high-performance compression solutions. With a strong global presence and innovation-driven approach, Convatec continues to expand its portfolio in the compression therapy sector.

Other key players in the market include Arjo AB, Medi USA LP, Sanyleg Srl, Tactile Systems Technology, Inc., BSN Medical GmbH, and Sigvaris Group.

Key Questions Answered in the Pneumatic Compression Therapy Market

• What was the global pneumatic compression therapy market value in 2024?
• What is the global pneumatic compression therapy market forecast outlook for 2025-2034?
• What is market segmentation based on products?
• What is market segmentation based on techniques?
• What is market segmentation based on application?
• What is market segmentation based on distribution channel?
• What are the major factors aiding the global pneumatic compression therapy market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major global pneumatic compression therapy market trends?
• Which products will lead the market segment?
• Which techniques will lead the market segment?
• Which application will hold a major segment of the market?
• Which distribution channel will lead the market segment?
• Who are the key players involved in the global pneumatic compression therapy market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.